advertisement
PURPOSE: The aim of this study was the evaluation of beta-blockers efficiency (as a monotherapy) in the lowering of IOP and the evolution of the visual field. MATERIAL AND METHOD: An observational clinical study was carried out over a determined period of time (January 2005-January 2007) on a number of 73 eyes with primary open-angle glaucoma in which one parameter was observed: IOP; on a number of 77 eyes with primary open-angle glaucoma the evolution of the visual field, while receiving specific treatment, was observed. RESULTS: Pressure release situated at 21.65%, with initial medium IOP at 23.95, and a final value of 17.51; p <0.0001. The aspect of the visual field suffered no negative transformations and no improvements either. The MD and PD parameters were recorded. CONCLUSIONS Beta-blockers can be efficient in monotherapy by offering the reduction and stabilisation of IOP. No problems with regard to tolerability in the eyes observed; no negative side effects emerged because it was not administered to patients which suffered from heart diseases or bronchial asthma. However, patient satisfaction is reduced by an administration of twice a day. LA: Romanian
X. Dobre. Spitalul De Urgenta Sf. Apostol Andrei Galati.
11.3.4 Betablocker (Part of: 11 Medical treatment > 11.3 Adrenergic drugs)